arginine has been researched along with Leukemia L 1210 in 41 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 29 (70.73) | 18.7374 |
| 1990's | 11 (26.83) | 18.2507 |
| 2000's | 1 (2.44) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cieśla, J; Gołos, B; Jagielska, E; Płucienniczak, A; Rode, W; Wałajtys-Rode, E | 1 |
| Drapier, JC; Hirling, H; Kaldy, P; Kühn, LC; Wietzerbin, J | 1 |
| Douzono, M; Hatake, K; Kawashima, T; Motoyoshi, K; Suzu, S; Yamada, M; Yanai, N | 1 |
| Aswad, GD; Wakim, BT | 1 |
| Chmurzyńska, W; Grzelakowska-Sztabert, B; Manteuffel-Cymborowska, M; Peska, M | 1 |
| Rabinovitz, M; Toal, JN; Vistica, DT | 1 |
| Hacker, MP; Huot, AE; Kruszyna, H; Kruszyna, R; Smith, RP | 1 |
| Hacker, MP; Huot, AE | 1 |
| Kwon, NS; Nathan, CF; Stuehr, DJ | 1 |
| Bishop, JA; Bisset, GM; Calvert, AH; Hughes, LR; Jackman, AL; Marsham, PR; O'Connor, BM; Oldfield, J; Thornton, TJ | 1 |
| Nathan, CF; Stuehr, DJ | 1 |
| Klostergaard, J; Leroux, ME | 1 |
| Gorbacheva, LB; Kukushkina, GV | 1 |
| Burton, AF; Storr, JM | 1 |
| Glisson, B; Liu, L; Ross, W; Rowe, T; Yalowich, J | 1 |
| Lee, T; Roberts, D | 2 |
| Hacker, M; Jackson, CW; Roberts, D | 1 |
| Hilliard, S; Peck, C; Roberts, D | 1 |
| Carter, SK; Slavik, M | 1 |
| Adamson, RH; Mead, JA; Sieber, SM | 1 |
| Hilliard, SL; Roberts, D | 1 |
| Allen, LM | 1 |
| Coulter, D; Kalish, R; Valeriote, FA; Vietti, TJ | 1 |
| Allen, L | 1 |
| Hacker, M; Roberts, D | 1 |
| Stähelin, H | 1 |
| Avery, T; Rivera, G; Roberts, DW | 1 |
| Kohn, KW; Orr, A; Pommier, Y; Riou, JF | 1 |
| Capranico, G; Kohn, KW; Orr, A; Pommier, Y | 1 |
| Frank, N; Osswald, H | 1 |
| Beerman, TA; Sigmund, RD; Woynarowski, JM | 2 |
| Foglesong, PD; Parganas, E; Roberts, DW; Wiggins, L | 1 |
| Fesen, M; Pommier, Y | 1 |
| Ellis, AL; Gewirtz, DA; Povirk, LF; Randolph, JK; Swerdlow, PS; Yalowich, JC; Yanovich, S | 1 |
| Biedler, JL; Meyers, MB; Roberts, D; Wiggins, LG | 1 |
| Kerrigan, D; Kohn, KW; Pommier, Y | 1 |
| Ashmun, R; Lee, T; Parganas, E; Roberts, D; Wiggins, L; Yalowich, J | 1 |
| Campbell, ED; Carter, WH; Goldman, ID; Wampler, GL | 1 |
| Bresson, ML; Cattan, A | 1 |
2 review(s) available for arginine and Leukemia L 1210
| Article | Year |
|---|---|
Investigational drugs under study by the United States National Cancer Institute.
Topics: Acrylates; Alkylating Agents; Ancitabine; Animals; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Azacitidine; Chemical Phenomena; Chemistry; Chromomycins; Cisplatin; DNA, Neoplasm; Drug Evaluation, Preclinical; Etoposide; Humans; Ifosfamide; Leukemia L1210; Mice; Mitosis; National Institutes of Health (U.S.); Neoplasms; Neoplasms, Experimental; Razoxane; Tegafur; Teniposide; United States | 1976 |
Pharmacology of antitumor agents from higher plants.
Topics: Animals; Antineoplastic Agents, Phytogenic; Aporphines; Camptothecin; Carcinoma, Squamous Cell; Chemical Phenomena; Chemistry; Etoposide; Humans; Leukemia L1210; Leukemia, Experimental; Leukemia, Lymphoid; Maytansine; Melanoma; Naphthoquinones; Nasopharyngeal Neoplasms; Neoplasms; Neoplasms, Experimental; Phenanthrenes; Structure-Activity Relationship; Teniposide; Vinblastine; Vincristine | 1976 |
39 other study(ies) available for arginine and Leukemia L 1210
| Article | Year |
|---|---|
The effect of Arg209 to Lys mutation in mouse thymidylate synthase.
Topics: Amino Acid Substitution; Animals; Arginine; Catalysis; Deoxyuracil Nucleotides; Enzyme Induction; Escherichia coli; Kinetics; Lacticaseibacillus casei; Leukemia L1210; Lysine; Mice; Recombinant Proteins; Solubility; Thymidylate Synthase; Tumor Cells, Cultured | 2002 |
Biosynthesis of nitric oxide activates iron regulatory factor in macrophages.
Topics: Aconitate Hydratase; Adenocarcinoma; Amino Acid Oxidoreductases; Animals; Arginine; Cell Line; Cells, Cultured; Enzyme Induction; Interferon-gamma; Iron-Regulatory Proteins; Kinetics; Leukemia L1210; Lipopolysaccharides; Macrophage Activation; Macrophages, Peritoneal; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mitochondria; Molsidomine; Nitric Oxide; Nitric Oxide Synthase; Nitrites; Recombinant Proteins; RNA-Binding Proteins; Tumor Cells, Cultured | 1993 |
Augmentation of cancer chemotherapy by preinjection of human macrophage colony-stimulating factor in L1210 leukemic cell-inoculated mice.
Topics: Amino Acid Oxidoreductases; Animals; Arginine; Doxorubicin; Kinetics; Leukemia L1210; Liver; Macrophage Colony-Stimulating Factor; Macrophages, Peritoneal; Male; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Nitric Oxide Synthase; omega-N-Methylarginine; Spleen; Survival Rate | 1995 |
Ca(2+)-calmodulin-dependent phosphorylation of arginine in histone 3 by a nuclear kinase from mouse leukemia cells.
Topics: Amino Acid Sequence; Animals; Arginine; Calcium-Calmodulin-Dependent Protein Kinases; Cell Nucleus; Chromatography, Affinity; Chromatography, Gel; Chromatography, High Pressure Liquid; Cyanogen Bromide; Histones; Leukemia L1210; Mice; Molecular Sequence Data; Peptide Fragments; Phosphopeptides; Phosphoproteins; Phosphorylation; Protamine Kinase; Substrate Specificity; Tumor Cells, Cultured | 1994 |
Tumour effect on arginine/ornithine metabolic relationship in hypertrophic mouse kidney.
Topics: Animals; Arginase; Arginine; Carcinoma, Ehrlich Tumor; Female; Hyperplasia; Kidney; Leukemia L1210; Mice; Mice, Inbred DBA; Ornithine; Ornithine Decarboxylase; Ornithine-Oxo-Acid Transaminase; Testosterone | 1997 |
Amino acid conferred protection against melphalan: interference with leucine protection of melphalan cytotoxicity by the basic amino acids in cultured murine L1210 leukemia cells.
Topics: Amino Acids; Aminobutyrates; Animals; Arginine; Cell Survival; Cells, Cultured; Culture Media; Drug Antagonism; Guanidines; Leucine; Leukemia L1210; Melphalan; Mice; Structure-Activity Relationship; Time Factors | 1978 |
Formation of nitric oxide hemoglobin in erythrocytes co-cultured with alveolar macrophages taken from bleomycin treated rats.
Topics: Animals; Arginine; Bleomycin; Cell Communication; Cells, Cultured; Erythrocytes; Hemoglobins; Inflammation; Leukemia L1210; Macrophages, Alveolar; Male; Mice; Nitric Oxide; Nitrites; omega-N-Methylarginine; Rats; Rats, Inbred Strains; Spectrophotometry | 1992 |
Role of reactive nitrogen intermediate production in alveolar macrophage-mediated cytostatic activity induced by bleomycin lung damage in rats.
Topics: Aconitate Hydratase; Animals; Arginine; Bleomycin; Cytotoxicity, Immunologic; DNA Replication; Kinetics; Leukemia L1210; Lung; Macrophage Activation; Macrophages; Male; Mice; Nitriles; Nitrites; omega-N-Methylarginine; Rats; Rats, Inbred Strains; Reference Values | 1990 |
Inhibition of tumor cell ribonucleotide reductase by macrophage-derived nitric oxide.
Topics: Amino Acid Oxidoreductases; Animals; Arginine; Cell Line; Copper; Copper Sulfate; Ferredoxins; Gas Chromatography-Mass Spectrometry; Hydroxyurea; Interferon-gamma; Kinetics; Leukemia L1210; Macrophages; Mice; Nitric Oxide; Nitric Oxide Synthase; Nitrites; Ribonucleotide Reductases | 1991 |
Quinazoline antifolate thymidylate synthase inhibitors: benzoyl ring modifications in the C2-methyl series.
Topics: Animals; Antineoplastic Agents; Arginine; Cell Division; Folic Acid Antagonists; Leukemia L1210; Mice; Molecular Structure; Quinazolines; Structure-Activity Relationship; Thymidylate Synthase | 1990 |
Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells.
Topics: Animals; Arginine; Cell Survival; Cells, Cultured; DNA; Free Radicals; Interferon-gamma; Leukemia L1210; Lipopolysaccharides; Macrophage Activation; Macrophages; Mice; Myoglobin; Nitrates; Nitric Oxide; Nitrogen Dioxide; Oxygen Consumption | 1989 |
L-arginine independent macrophage tumor cytotoxicity.
Topics: Animals; Arginine; Chromium Radioisotopes; Cytotoxicity, Immunologic; Glucose; Iron Radioisotopes; Leukemia L1210; Macrophage Activation; Macrophages; Mycobacterium bovis; Neoplasms; omega-N-Methylarginine; Tumor Cells, Cultured | 1989 |
Some aspects of the mechanism of action of 1-propyl-1-nitrosourea.
Topics: Amino Acids; Animals; Arginine; Carbon Isotopes; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Cell Line; Centrifugation, Density Gradient; Chlorophyta; DNA, Neoplasm; Formates; Histones; Leukemia L1210; Liver; Liver Neoplasms; Lysine; Mice; Molecular Weight; Neoplasm Proteins; Neoplasms, Experimental; Nitroso Compounds; Nitrosourea Compounds; Protein Hydrolysates; RNA, Neoplasm; RNA, Ribosomal; RNA, Transfer; Spleen; Time Factors; Urea | 1970 |
The effects of arginine deficiency on lymphoma cells.
Topics: Animals; Arginase; Arginine; Carbon Radioisotopes; Cell Count; Cell Line; Cell Survival; Cells, Cultured; Citrulline; Leucine; Leukemia L1210; Leukemia, Lymphoid; Lymphoma, Non-Hodgkin; Mice; Neoplasms, Experimental; Ornithine; Succinates; Thymidine; Tritium; Uridine | 1974 |
Role of topoisomerase II in mediating epipodophyllotoxin-induced DNA cleavage.
Topics: Animals; Cattle; Cell Nucleus; Cell Survival; DNA Topoisomerases, Type II; DNA, Neoplasm; Etoposide; Leukemia L1210; Mice; Podophyllotoxin; Structure-Activity Relationship; Teniposide; Thymus Gland | 1984 |
Flux of teniposide (VM-26) across the plasma membrane of teniposide-resistant sublines of L1210 cells.
Topics: Animals; Biological Transport; Cell Membrane; Drug Resistance; Kinetics; Leukemia L1210; Mice; Mutation; Podophyllotoxin; Teniposide | 1984 |
Selection and characterization of L1210 sublines resistant to teniposide (VM-26).
Topics: Animals; Cell Division; Chromosome Banding; Clone Cells; Drug Resistance; Karyotyping; Kinetics; Leukemia L1210; Metaphase; Mice; Mutation; Podophyllotoxin; Teniposide | 1984 |
Effect of VM-26 on the haematological responses of mice to L1210 leukaemia.
Topics: Animals; Female; Hematocrit; Leukemia L1210; Leukocyte Count; Mice; Neoplasm Transplantation; Platelet Count; Podophyllotoxin; Teniposide; Transplantation, Homologous | 1980 |
Sedimentation of DNA from L1210 cells after treatment with 4'-demethylepipodophyllotoxin-9-(4,6-O-2-thenylidene-beta-D-glucopyranoside) or 1-beta-D-arabinofuranosylcytosine or both drugs.
Topics: Animals; Antibiotics, Antineoplastic; Centrifugation, Density Gradient; Cytarabine; Dose-Response Relationship, Drug; Drug Interactions; Leukemia L1210; Mice; Podophyllotoxin; Teniposide; Time Factors | 1980 |
Combination chemotherapy in sequence for the treatment of L1210 leukemia.
Topics: Animals; Antineoplastic Agents; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Female; Leukemia L1210; Methotrexate; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Teniposide; Therapeutic Equivalency | 1978 |
Comparison of uptake and binding of two epipodophyllotoxin glucopyranosides, 4'-demethyl epipodophyllotoxin thenylidene-beta-D-glucoside and 4'-demethyl epipodophyllotoxin ethylidene-beta-D-glucoside, in the L1210 leukemia cell.
Topics: Animals; Binding Sites; Biological Transport; Cell Nucleus; Etoposide; Kinetics; Leukemia L1210; Mice; Mice, Inbred DBA; Podophyllotoxin; Teniposide; Thermodynamics; Vinblastine | 1978 |
Kinetics of cytotoxicity of VM-26 and VP-16-213 on L1210 leukemia and hematopoietic stem cells.
Topics: Animals; Cell Survival; Colony-Forming Units Assay; Dose-Response Relationship, Drug; Etoposide; Hematopoietic Stem Cells; Leukemia L1210; Podophyllotoxin; Rats; Teniposide; Time Factors | 1978 |
The role of drug disposition kinetics on cellular transport of the antineoplastic agent VM-26.
Topics: Animals; Biological Transport, Active; Chemical Phenomena; Chemistry; Diffusion; Etoposide; Kinetics; Leukemia L1210; Mice; Models, Biological; Podophyllotoxin; Protein Binding; Serum Albumin; Teniposide | 1978 |
VM26-induced changes in hepatic intermediary metabolism of mice.
Topics: Animals; Blood Glucose; Doxorubicin; Drug Synergism; Female; Glucose; Hexosephosphates; In Vitro Techniques; Isocitrates; Ketoglutaric Acids; Leukemia L1210; Liver; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Mitochondria, Liver; Oxygen Consumption; Podophyllotoxin; Succinates; Teniposide | 1977 |
Delayed toxicity of epipodophyllotoxin derivatives (VM 26 and VP 16-213), due to a local effect.
Topics: Animals; Dose-Response Relationship, Drug; Etoposide; Female; Injections, Intraperitoneal; Injections, Intravenous; Leukemia L1210; Liver; Lung; Male; Mice; Organ Size; Podophyllotoxin; Rats; Teniposide; Time Factors | 1976 |
Response of L1210 to combinations of cytosine arabinoside and VM-26 or VP16-213.
Topics: Animals; Cytarabine; Drug Therapy, Combination; Etoposide; Female; Leukemia L1210; Leukemia, Experimental; Mice; Podophyllotoxin; Pyrans; Teniposide | 1975 |
Differential effects of amsacrine and epipodophyllotoxins on topoisomerase II cleavage in the human c-myc protooncogene.
Topics: Amsacrine; Animals; Base Sequence; Binding Sites; Carcinoma, Small Cell; Cell Line; DNA Damage; DNA Topoisomerases, Type II; DNA, Neoplasm; Etoposide; Genes, myc; Humans; Leukemia L1210; Lung Neoplasms; Mice; Molecular Sequence Data; Promoter Regions, Genetic; Restriction Mapping; Substrate Specificity; Teniposide | 1992 |
Distribution of topoisomerase II cleavage sites in simian virus 40 DNA and the effects of drugs.
Topics: Amsacrine; Animals; Base Sequence; Daunorubicin; DNA Damage; DNA Replication; DNA Topoisomerases, Type II; DNA, Viral; Ellipticines; Genome, Viral; Kinetics; Leukemia L1210; Mice; Molecular Sequence Data; Restriction Mapping; Simian virus 40; Substrate Specificity; Teniposide | 1991 |
Sacrosine- and prolinedithiocarbamate pretreatment increases the therapeutic efficacy of doxorubicin, methotrexate, teniposide, mitoxantrone or cyclohexylchloroethylnitrosourea in leukemia L1210.
Topics: Animals; Antineoplastic Agents; Cysteine; Doxorubicin; Drug Synergism; Female; Leukemia L1210; Lomustine; Methotrexate; Mice; Mice, Inbred DBA; Mitoxantrone; Proline; Sarcosine; Teniposide; Thiocarbamates | 1990 |
DNA minor groove binding agents interfere with topoisomerase II mediated lesions induced by epipodophyllotoxin derivative VM-26 and acridine derivative m-AMSA in nuclei from L1210 cells.
Topics: Amsacrine; Animals; Bisbenzimidazole; Cell Nucleus; Deoxyribonucleoproteins; Distamycins; DNA Damage; DNA, Neoplasm; Indoles; Kinetics; Leukemia L1210; Mice; Podophyllotoxin; Teniposide; Topoisomerase II Inhibitors | 1989 |
Reduced formation of lesions in the DNA of a multidrug-resistant L1210 subline selected for teniposide resistance.
Topics: Animals; DNA; DNA Damage; DNA Topoisomerases, Type II; Doxorubicin; Drug Resistance; Leukemia L1210; Podophyllotoxin; Potassium Cyanide; Teniposide; Tumor Cells, Cultured; Verapamil | 1989 |
Mammalian topoisomerase II activity is modulated by the DNA minor groove binder distamycin in simian virus 40 DNA.
Topics: Animals; Base Sequence; Binding Sites; Distamycins; DNA Restriction Enzymes; DNA Topoisomerases, Type II; DNA, Viral; Drug Interactions; Electrophoresis; Leukemia L1210; Mice; Molecular Sequence Data; Nucleic Acid Conformation; Pyrroles; Repetitive Sequences, Nucleic Acid; Simian virus 40; Teniposide; Tumor Cells, Cultured | 1989 |
Expression of protein-associated DNA damage in the alkaline elution assay in the absence of enzymatic deproteinization.
Topics: Animals; Cell Line; DNA Damage; DNA Replication; DNA Topoisomerases, Type II; DNA, Neoplasm; Endopeptidase K; Etoposide; Humans; Hydrogen-Ion Concentration; Leukemia L1210; Liver Neoplasms, Experimental; Mice; Mitoxantrone; Podophyllotoxin; Protein Binding; Rats; Serine Endopeptidases; Teniposide; Tumor Cells, Cultured | 1989 |
Topoisomerase-II-mediated lesions in nascent DNA: comparison of the effects of epipodophyllotoxin derivatives, VM-26 and VP-16, and 9-anilinoacridine derivatives, m-AMSA and o-AMSA.
Topics: Adenosine Triphosphate; Amsacrine; Animals; Cross-Linking Reagents; DNA; DNA Damage; DNA Replication; DNA Topoisomerases, Type II; DNA, Neoplasm; Etoposide; Leukemia L1210; Mice; Novobiocin; Podophyllotoxin; Teniposide; Topoisomerase II Inhibitors | 1988 |
Association of sorcin with drug resistance in L1210 cells.
Topics: Animals; Calcium-Binding Proteins; Drug Resistance; Electrophoresis, Polyacrylamide Gel; Gene Amplification; Leukemia L1210; Neoplasm Proteins; Teniposide | 1989 |
Protein-linked DNA strand breaks produced by etoposide and teniposide in mouse L1210 and human VA-13 and HT-29 cell lines: relationship to cytotoxicity.
Topics: Animals; Cell Line; Cell Survival; DNA Topoisomerases, Type II; DNA, Neoplasm; Etoposide; Humans; Kinetics; Leukemia L1210; Podophyllotoxin; Teniposide | 1987 |
Expressions of resistance and cross-resistance in teniposide-resistant L1210 cells.
Topics: Animals; Antineoplastic Agents; Cell Cycle; Cell Line; Cyanides; Drug Resistance; Leukemia L1210; Lipid Metabolism; Mice; Neoplasm Proteins; Phenotype; Podophyllotoxin; Teniposide; Verapamil | 1987 |
Demonstration of a schedule-dependent therapeutic synergism utilizing the interacting drugs methotrexate and teniposide in L1210 leukemia.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug Synergism; Leukemia L1210; Mathematics; Methotrexate; Mice; Mice, Inbred Strains; Models, Biological; Statistics as Topic; Teniposide | 1987 |
Vitamin A: failure to demonstrate in mice an anti-tumour effect, whether combined with cytotoxic drugs or not.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Cyclophosphamide; Etoposide; Female; Leukemia L1210; Leukemia, Experimental; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Neoplasm Transplantation; Neoplasms, Experimental; Teniposide; Vitamin A | 1986 |